RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-1505
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_1349800; Gene model (P.falciparum): PF3D7_1335900; Gene product: thrombospondin-related anonymous protein | sporozoite surface protein 2 (sporozoite surface protein 2; SSP2; SSP-2; TRAP)
Name tag: GFP
Phenotype Sporozoite;
Last modified: 20 July 2016, 11:16
  *RMgm-1505
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 27427910
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherKehrer J; Mair GR
Name Group/DepartmentIntegrative Parasitology, Center for Infectious Diseases
Name InstituteUniversity of Heidelberg Medical School
CityHeidelberg
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-1505
Principal namess::gfp::trap
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot tested
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteA faint, speckled surface signal in non-permeabilized sporozoites.
SS::GFP::TRAP is expressed in midgut and salivary gland sporozoites with a localisation consistent with wildtype TRAP. Sporozoites are motile.
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses an N-terminal GFP-tagged version of TRAP

Protein (function)
TRAP is a type 1 transmembrane protein, containing two adhesive domains in its extracellular portion, an A-domain of von Willebrand factor and a thrombospondin type I repeat (TSR, TSP). The cytoplasmic part (tail) of the protein is postulated to interact with actin–myosin motor proteins giving the force needed for motility.
TRAP is located in the micronemes of sporozoites. The protein plays a role in the gliding motility of sporozoites and invasion of host cells as has been shown by analysis of mutant parasites lacking expression of TRAP.
Analyses of mutants that express TRAP with mutated forms of the cytoplasmic tail have shown the role of this domain for gliding motility and invasion of host cells.

Phenotype
A faint, speckled surface signal in non-permeabilized sporozoites.
SS::GFP::TRAP is expressed in midgut and salivary gland sporozoites with a localisation consistent with wildtype TRAP. Sporozoites are motile.

Additional information

Other mutants
See the link PF3D7_1335900 for other TRAP mutants


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1349800
Gene Model P. falciparum ortholog PF3D7_1335900
Gene productthrombospondin-related anonymous protein | sporozoite surface protein 2
Gene product: Alternative namesporozoite surface protein 2; SSP2; SSP-2; TRAP
Details of the genetic modification
Name of the tagGFP
Details of taggingN-terminal
Additional remarks: taggingTo tag TRAP with GFP at the N-terminal after signal peptide cleavage, 1054 bp of the 5’UTR of trap together with the first 105 bp of the coding region were cloned in front of GFP linked by a 6-amino acid linker. This was followed by an 8-amino acid linker, the rest of the coding sequence of trap, followed by 514 bp of the 3’ UTR region of dhfs, followed by a hdhfr selection cassette. The pasmid was linearized with BstBI within the TRAP 5’UTR resulting in introduction of SS::GFP::TRAP by single crossover integration.
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6